Biolinq is a complete rethink of the CGM form factor, in a way that opens it to incredible opportunities beyond the traditional use cases.

The first liquid biopsy company that will clear FDA approvals for cancer diagnostics, with leading sensitivity and specificity. Freenome is revolutionizing early cancer detection with its cutting-edge multiomics test, an innovative fusion of tumor and non-tumor biomarkers, synthesized through advanced machine learning algorithms